Cardiovascular disease (CVD) is the most prevalent of all diseases with an estimated 60 million Americans and 100 million people in the developed world suffer from one or more forms of CVD.  
The cardiovascular drug market is large but the market is largely genericized.  We divide the cardiovascular market into six therapeutic segments (1) Angina (2) Anti-thrombotics, (3) Arrhythmia (4) Cholesterol (5) Congestive Heart Failure (CHF), and (6) Hypertension.